Global healthcare is in a crisis.
Yet from crisis can flow magnificent opportunity.
For the early pacesetters in the “Smart Healthcare” revolution, this time has come.
Such a ground-breaking approach promises to transform patient care and medical supply the world over.
As populations age, traditional healthcare providers are becoming increasingly overwhelmed.
There are simply not enough doctors and nurses to cope with demand, and money is running out.
Supply chain inefficiencies and medicine misuse are compounding the pressure.
The old ways of working are failing to keep pace with modern needs.
The situation was already acute before the Coronavirus struck.
Now that we are in a global economic lockdown, it is much worse.
Where exactly do we go from here?
Well, Smart Healthcare will lead the way.
The vision is clear – to empower patients to take more responsibility for their health, to test and track their progress and, above all, to treat themselves.
As various technologies have become more powerful, more miniaturized, and cheaper to produce, it has become possible to connect people, treatments, and medical facilities like never before.
Smart Healthcare will allow ordinary people to take a more proactive ‘hands-on’ approach to their health.
The cost savings will be immense.
We have already seen an explosion in mobile smart gadgets and health apps that can track daily wellbeing. Meanwhile, in the professional medical field, there has been a huge, parallel uptake in digitized interventions.
The next epic wave in this digital revolution will see personal and professional solutions collide in a tsunami of micro diagnostic and measuring devices.
But how will pioneering companies overcome the limitations, complexity and cost currently associated with mobile technologies?
How will they create devices small and simple enough to be effective on a global scale?
Enter the exciting field of printed electronics.
READ OUR SPECIAL REPORT to discover how Ynvisible’s printed electronics are set to transform the world around you (TSXV: YNV │OTCQB: YNVYF│1XNA:GR)
You might not have heard of printed electronics, but this technology will be at the forefront of the Smart Health mega-trend.
Manufacturers can now “print” paper-thin, flexible electronic displays that have sufficient power to act as communication devices.
Amazingly, the cost of doing so is low enough to enable the mass-production of hundreds of millions – or even billions – of units.
The enormous potential for this technology spans many sectors.
However, printed electronics could play a particularly decisive role in the Smart Healthcare revolution.
With its range of patented and proprietary electronic inks, Ynvisible Interactive Inc. (TSXV: YNV │OTCQB: YNVYF│1XNA:GR) is in pole position to become one of the biggest winners in this next multi-billion dollar industry.
This company already has an overflowing sales pipeline, full of some of the world’s largest and most recognised brands.
Ynvisible’s technology is so cutting-edge that these leads are kept under the strictest secret, until the prototypes are ready for mass-market distribution. Once they break from cover, the world around us will never be the same again.
Are you ready to profit?
VIDEO PITCH –The game-changing deal with Identiv for Ynvisible (TSXV: YNV │OTCQB: YNVYF│1XNA:GR)
Watch this video pitch to learn how Ynvisible’s market-leading printed electronic displays deliver a vital competitive edge
In December 2019, Ynvisible secured its first major go-to-market development partnership with Identiv (NASDAQ:INVE).
This $52.5 million firm is a global supplier of physical security and secure identification.
Globally, Identiv boasts more than 5,000 customers. Major clients include the US federal government and some of the largest players in the health, transportation, education, and commercial sectors.
Among Identiv’s key product lines are cold-chain offerings like temperature trackers and contactless smart card readers. Traditionally, data from sensors is stored and read by mobile devices or uploaded to the cloud for analytics and remediation.
However, thanks to advances in printed electronics, it is now possible to print “Smart Labels” that perform the entire role immediately and on-site.
To this end, Identiv chose Ynvisible as its development partner to upgrade its uTrust Sense temperature trackers.
Using Ynvisible’s electronic inks, Identiv can now print smart labels that track temperatures directly and give instant readings “in the field”.
The uTrust Sense temperature tracker is activated when temperature readings exceed or fall below defined ranges.
For the transportation of valuable and perishable medicines and medical goods this is extremely important.
Drugs or supplies like blood bags that have not been shipped in the right temperature conditions can be rendered unusable and wasted. This is a common problem across the sector. Printed electronic devices, such as the uTrust Sense temperature tracker, provide a highly cost-effective solution at scale.
From Smart Labels to wearable diagnostic devices – the $300 billion Smart Healthcare opportunity for Ynvisible’s electronic inks (TSXV: YNV │OTCQB: YNVYF│1XNA:GR)
The adoption of Smart Healthcare technology is accelerating.
Specialized micro-sensors and smart devices are being deployed to create end-to-end treatment platforms at an astonishing rate.
A report from leading investment bank Goldman Sachs forecasts that these innovations, combined with other mobile technology, will save the United States alone over $300 billion a year in healthcare costs.
To give a real-world example, consider the treatment for diabetes.
There are currently 415 million diabetics around the world. The number of sufferers is forecast to grow to 640 million by 2040.
The treatment of diabetes has become one of the global healthcare system’s greatest burdens.
Insulin, the hormone required to manage diabetes, is notoriously difficult to transport. It spoils easily if not kept in the right temperature conditions, and has a limited shelf life.
Products like the uTrust Sense temperature tracker can help to ensure the safe transportation and storage of insulin, but what about ongoing treatment?
For most diabetic patients, their condition is relatively straightforward.
Equipped with simple-to-use devices, the majority should rarely need to visit a doctor. However, until such devices become widely availably they will continue to take up a disproportionately high amount of medical attention.
As part of the Smart Healthcare revolution, printed electronics offers a range of potential remedies.
Traditional monitoring equipment, which continuously measures glucose and regulates insulin intake, is expensive to produce and reserved for those most at risk.
However, discrete printed electronic patches could very soon provide a low-cost and highly-effective alternative to this outdated technology.
In fact, the potential applications for printed electronic patches extend far beyond the needs of diabetics alone.
New designs are already emerging for monitoring heart rates, body temperature, dehydration, and various other indicators of a patient’s wellbeing.
This is happening so rapidly, that it is quite possible to imagine a point when printed electronic patches suddenly appear on the arms of hundreds of millions of people around the planet. You wouldn’t even notice it happen.
Market reporter IDTechEx forecasts that the market for electronic skin patches will grow from $6 billion in 2019 to $10 billion by 2024. It also predicts the overall medical wearables market to double between 2019 and 2024 to $19.7 billion.
Given the elegance and simplicity of wafer-thin, flexible printed electronic solutions, this presents an incredible opportunity for Ynvisible (TSXV: YNV │OTCQB: YNVYF│1XNA:GR) and its market-leading inks for electronic display printing.
DOWNLOAD OUR EXCLUSIVE REPORT to uncover a company at the cutting edge of a technological revolution – Ynvisible Interactive Inc. (TSXV: YNV │OTCQB: YNVYF│1XNA:GR)
IMPORTANT NOTICE AND DISCLAIMER
This communication is a paid advertisement. ValueTheMarkets is a trading name of Digitonic Ltd, and its owners, directors, officers, employees, affiliates, agents and assigns (collectively the “Publisher”) is often paid by one or more of the profiled companies or a third party to disseminate these types of communications. In this case, the Publisher has been compensated by Ynvisible Interactive Inc to conduct investor awareness advertising and marketing and has paid the Publisher the equivalent of one hundred thousand USD to produce and disseminate this and other similar articles and certain related banner advertisements. This compensation should be viewed as a major conflict with the Publisher’s ability to provide unbiased information or opinion.
Changes in Share Trading and Price
Readers should beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you receive this communication, which has the potential to adversely affect share prices. Frequently companies profiled in our articles experience a large increase in share trading volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases. The investor awareness marketing may be as brief as one day, after which a large decrease in share trading volume and share price may likely occur.
No Offer to Sell or Buy Securities
This communication is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security.
Neither this communication nor the Publisher purport to provide a complete analysis of any company or its financial position.
This communication is based on information generally available to the public and on an interview conducted with the company’s CEO, and does not contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the Publisher does not guarantee the accuracy or completeness of the information. Further, the information in this communication is not updated after publication and may become inaccurate or outdated. No reliance should be placed on the price or statistics information and no responsibility or liability is accepted for any error or inaccuracy.
No Financial Advice
The Publisher is not, and does not purport to be, a broker-dealer or registered investment adviser or a financial adviser. The Publisher has no access to non-public information about publicly traded companies. The information provided is general and impersonal, and is not tailored to any particular individual’s financial situation or investment objective(s) and this communication is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor or a personal recommendation to deal or invest in any particular company or product. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company’s SEC, SEDAR and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk. Past performance does not guarantee future results.
Forward Looking Statements
This communication contains forward-looking statements, including statements regarding expected continual growth of the featured companies and/or industry. Statements in this communication that look forward in time, which include everything other than historical information, are based on assumptions and estimates by our content providers and involve risks and uncertainties that may affect the profiled company’s actual results of operations. These statements involve known and unknown risks, uncertainties and other important factors that could cause the actual results and performance to differ materially from any future results or performance expressed or implied in the forward-looking statements. These risks, uncertainties and other factors include, among others: the success of the profiled company’s operations; the size and growth of the market for the company’s products and services; the company’s ability to fund its capital requirements in the near term and long term; pricing pressures; changes in business strategy, practices or customer relationships; general worldwide economic and business conditions; currency exchange and interest rate fluctuations; government, statutory, regulatory or administrative initiatives affecting the company’s business.
Indemnification/Release of Liability
By reading this communication, you acknowledge that you have read and understand this disclaimer in full, and agree and accept that the Publisher provides no warranty in respect of the communication or the profiled company and accepts no liability whatsoever. You acknowledge and accept this disclaimer and that, to the greatest extent permitted under applicable law, you release and hold harmless the Publisher from any and all liability, damages, injury and adverse consequences arising from your use of this communication. You further agree that you are solely responsible for any financial outcome related to or arising from your investment decisions.
All trademarks used in this communication are the property of their respective trademark holders. Other than Valuethemarkets.com, the Publisher is not affiliated, connected, or associated with, and the communication is not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by the Publisher to any rights in any third-party trademarks other than Valuethemarkets.com.
Valuethemarkets.com and Digitonic Ltd and our affiliates are not responsible for the content or accuracy of this article. The information included in this article is based solely on information provided by the company or companies mentioned above.
This article does not provide any financial advice and is not a recommendation to deal in any securities or product. News and research are not recommendations to deal, and investments may fall in value so that you could lose some or all of your investment. Past performance is not an indicator of future performance.
Ben Turney does not hold any position in the stock(s) and/or financial instrument(s) mentioned in the above piece. Ben Turney has been paid to produce this piece by the company or companies mentioned above. Digitonic Ltd, the owner of ValueTheMarkets.com, has been paid for the production this piece by the company or companies mentioned above.